Last Articles

A medical device company focused on treatment options for patients diagnosed with infertility.

Elkin Lucena of the Columbian Fertility and Sterility Center in Bogota, Colombia presented the outcomes of the Center’s first 95 fertility treatment cycles making use of INVO Bioscience’s INVOcell for lovers with fertility problems at the 66th Annual Interacting with of the American Society of Reproductive Medicine in Denver. This outstanding effectiveness was achieved in cycles finished in women from age groups 21 to 45. The clinical pregnancy rate for patients aged 40 and younger was 46 percent. According to the U.S. Center for Disease Control current infertility treatments are in the same selection of efficacy. The CECOLFES outcomes also indicated that multiple pregnancies happened in 10 percent of the individuals in the study in comparison to 30 percent multiple pregnancies that take place in more traditional fertility treatment regimes.The speedy economic development and the concurrent urbanization of poorer countries imply that developing-country cities will be both vulnerable to side effects from climate modification and, simultaneously, an increasing contributor to the issue. Climate Change and Developing-Country Cities, one of the articles in today’s supplement to Springer’s Journal of Urban Wellness focuses on the implications for environmental health insurance and equity.